dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Wright, Sarah Christine Elisabeth |
dc.contributor.author | Vasilevski, Natali |
dc.contributor.author | Serra Elizalde, Violeta |
dc.contributor.author | Rodon Ahnert, Jordi |
dc.contributor.author | Eichhorn, Pieter Johan Adam |
dc.date.accessioned | 2022-03-21T08:37:36Z |
dc.date.available | 2022-03-21T08:37:36Z |
dc.date.issued | 2021-04 |
dc.identifier.citation | Wright SCE, Vasilevski N, Serra V, Rodon J, Eichhorn PJA. Mechanisms of Resistance to PI3K Inhibitors in Cancer: Adaptive Responses, Drug Tolerance and Cellular Plasticity. Cancers. 2021 Apr;13(7):1538. |
dc.identifier.issn | 2072-6694 |
dc.identifier.uri | https://hdl.handle.net/11351/7210 |
dc.description | Inhibidors de la via PI3K; Mecanismes de resistència |
dc.description.sponsorship | The work was funded by a start-up grant provided by Curtin University. |
dc.language.iso | eng |
dc.publisher | MDPI |
dc.relation.ispartofseries | Cancers;13(7) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Càncer - Tractament |
dc.subject | Resistència als medicaments |
dc.subject.mesh | Neoplasms |
dc.subject.mesh | /therapy |
dc.subject.mesh | Drug Resistance, Neoplasm |
dc.title | Mechanisms of Resistance to PI3K Inhibitors in Cancer: Adaptive Responses, Drug Tolerance and Cellular Plasticity |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.3390/cancers13071538 |
dc.subject.decs | neoplasias |
dc.subject.decs | /terapia |
dc.subject.decs | resistencia a los antineoplásicos |
dc.relation.publishversion | https://doi.org/10.3390/cancers13071538 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Wright SCE, Vasilevski N] Faculty of Health Sciences, Curtin Medical School, Curtin University, Bentley 6102, Australia. Curtin Health Innovation Research Institute and Faculty of Health Sciences, Curtin University, Bentley 6102, Australia. [Serra V] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Rodon J] MD Anderson Cancer Center, Investigational Cancer Therapeutics Department, Houston, TX 77030, USA. [Eichhorn PJA] Faculty of Health Sciences, Curtin Medical School, Curtin University, Bentley 6102, Australia. Curtin Health Innovation Research Institute and Faculty of Health Sciences, Curtin University, Bentley 6102, Australia. Cancer Science Institute of Singapore, National University of Singapore, Singapore 117599, Singapore. Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore |
dc.identifier.pmid | 33810522 |
dc.identifier.wos | 000638315800001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |